AR and prostate cancer: Post-translational modifications of α-tubulin have been shown to be associated with prostate cancer progression, with loss of acetylated α-tubulin a common feature in AR-negative castrate-resistant cell lines, suggesting a link between AR and acetylation of α-tubulin in prostate cancer [20].